X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
61
PharmaCompass offers a list of Chlorhexidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorhexidine manufacturer or Chlorhexidine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorhexidine manufacturer or Chlorhexidine supplier.
PharmaCompass also assists you with knowing the Chlorhexidine API Price utilized in the formulation of products. Chlorhexidine API Price is not always fixed or binding as the Chlorhexidine Price is obtained through a variety of data sources. The Chlorhexidine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chlorhexidine Base manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorhexidine Base, including repackagers and relabelers. The FDA regulates Chlorhexidine Base manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorhexidine Base API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorhexidine Base manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorhexidine Base supplier is an individual or a company that provides Chlorhexidine Base active pharmaceutical ingredient (API) or Chlorhexidine Base finished formulations upon request. The Chlorhexidine Base suppliers may include Chlorhexidine Base API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorhexidine Base suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlorhexidine Base DMF (Drug Master File) is a document detailing the whole manufacturing process of Chlorhexidine Base active pharmaceutical ingredient (API) in detail. Different forms of Chlorhexidine Base DMFs exist exist since differing nations have different regulations, such as Chlorhexidine Base USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chlorhexidine Base DMF submitted to regulatory agencies in the US is known as a USDMF. Chlorhexidine Base USDMF includes data on Chlorhexidine Base's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chlorhexidine Base USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chlorhexidine Base suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Chlorhexidine Base Drug Master File in Japan (Chlorhexidine Base JDMF) empowers Chlorhexidine Base API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Chlorhexidine Base JDMF during the approval evaluation for pharmaceutical products. At the time of Chlorhexidine Base JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Chlorhexidine Base suppliers with JDMF on PharmaCompass.
A Chlorhexidine Base written confirmation (Chlorhexidine Base WC) is an official document issued by a regulatory agency to a Chlorhexidine Base manufacturer, verifying that the manufacturing facility of a Chlorhexidine Base active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chlorhexidine Base APIs or Chlorhexidine Base finished pharmaceutical products to another nation, regulatory agencies frequently require a Chlorhexidine Base WC (written confirmation) as part of the regulatory process.
click here to find a list of Chlorhexidine Base suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chlorhexidine Base as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chlorhexidine Base API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chlorhexidine Base as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chlorhexidine Base and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chlorhexidine Base NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chlorhexidine Base suppliers with NDC on PharmaCompass.
Chlorhexidine Base Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorhexidine Base GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorhexidine Base GMP manufacturer or Chlorhexidine Base GMP API supplier for your needs.
A Chlorhexidine Base CoA (Certificate of Analysis) is a formal document that attests to Chlorhexidine Base's compliance with Chlorhexidine Base specifications and serves as a tool for batch-level quality control.
Chlorhexidine Base CoA mostly includes findings from lab analyses of a specific batch. For each Chlorhexidine Base CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorhexidine Base may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorhexidine Base EP), Chlorhexidine Base JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorhexidine Base USP).
Market Place
